DE69822218D1 - Donepezil polykristalle und verfharen zu ihrer herstellung - Google Patents

Donepezil polykristalle und verfharen zu ihrer herstellung

Info

Publication number
DE69822218D1
DE69822218D1 DE69822218T DE69822218T DE69822218D1 DE 69822218 D1 DE69822218 D1 DE 69822218D1 DE 69822218 T DE69822218 T DE 69822218T DE 69822218 T DE69822218 T DE 69822218T DE 69822218 D1 DE69822218 D1 DE 69822218D1
Authority
DE
Germany
Prior art keywords
donepezil
polycrystals
procedure
production
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69822218T
Other languages
English (en)
Other versions
DE69822218T2 (de
Inventor
Akio Imai
Toshiyuki Ichinohe
Takashi Endo
Tomio Tsurugi
Makoto Uemura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18296352&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69822218(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE69822218D1 publication Critical patent/DE69822218D1/de
Publication of DE69822218T2 publication Critical patent/DE69822218T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Hydrogenated Pyridines (AREA)
DE69822218T 1997-12-05 1998-12-01 Donepezil polykristalle und verfharen zu ihrer herstellung Expired - Lifetime DE69822218T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33616597 1997-12-05
JP33616597 1997-12-05
PCT/JP1998/005405 WO1999029668A1 (fr) 1997-12-05 1998-12-01 Polycristaux de donepezil et leur procede de production

Publications (2)

Publication Number Publication Date
DE69822218D1 true DE69822218D1 (de) 2004-04-08
DE69822218T2 DE69822218T2 (de) 2005-02-03

Family

ID=18296352

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69822218T Expired - Lifetime DE69822218T2 (de) 1997-12-05 1998-12-01 Donepezil polykristalle und verfharen zu ihrer herstellung

Country Status (8)

Country Link
US (1) US6245911B1 (de)
EP (1) EP1048653B1 (de)
AT (1) ATE260896T1 (de)
DE (1) DE69822218T2 (de)
DK (1) DK1048653T3 (de)
ES (1) ES2218869T3 (de)
PT (1) PT1048653E (de)
WO (1) WO1999029668A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001249091A1 (en) 2000-03-03 2001-09-17 Eisai Co. Ltd. Novel methods using cholinesterase inhibitors
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
US20060014801A1 (en) * 2002-11-22 2006-01-19 The Johns Hopkins University Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs
EP1603548A4 (de) * 2003-02-05 2007-10-10 Myriad Genetics Inc Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen
US7439365B2 (en) * 2003-11-17 2008-10-21 Usv, Ltd. Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil)
AU2003230195A1 (en) * 2003-04-02 2004-10-25 Hetero Drugs Limited A novel process for amorphous form of donepezil hydrochloride
EP1776089A2 (de) * 2003-12-31 2007-04-25 Actavis Group hf Donepezil-formulierungen
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
KR20070004036A (ko) * 2004-04-29 2007-01-05 키스톤 리테이닝 월 시스템스, 아이엔씨 벽, 옹벽 및 그 외 유사한 것을 위한 베니어
CA2566204A1 (en) * 2004-05-14 2005-12-01 The Johns Hopkins University Method for improving cognitive function by co-administration of a gabab receptor antagonist and an acetylcholinesterase inhibitor
WO2006015338A2 (en) * 2004-07-30 2006-02-09 Dr. Reddy's Laboratories Ltd. Crystalline form of donepezil hydrochloride
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
IL171137A (en) * 2004-09-29 2012-01-31 Chemagis Ltd Use of purified malt donfazil for the preparation of pure pharmaceutical amorphous donfazil hydrochloride
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
CA2590533C (en) * 2004-11-23 2010-09-07 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
US20060122226A1 (en) * 2004-12-08 2006-06-08 Itai Adin Crystalline forms of Donepezil base
PL1871368T3 (pl) * 2005-04-04 2011-12-30 Eisai R&D Man Co Ltd Związki dihydropirydynowe do zastosowania w chorobach neurodegeneracyjnych i demencji
WO2007014124A2 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
CN104059013B8 (zh) * 2005-07-27 2016-09-21 纽若范斯有限公司 1-芳基-3-氮杂二环[3.1.0]己烷：其制备方法和用于治疗神经精神障碍的用途
US20070026075A1 (en) * 2005-07-28 2007-02-01 Jutaro Shudo Gelled donepezil compositions and methods for making and using the same
US20100113793A1 (en) * 2006-03-20 2010-05-06 Ind-Swift Laboratories Limited Process for the Preparation of Highly Pure Donepezil
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
JP5097359B2 (ja) * 2006-05-09 2012-12-12 久光製薬株式会社 ドネペジル経皮吸収型製剤
EP2046119A2 (de) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Behandlung von psychiatrischen störungen
WO2008050351A1 (en) * 2006-10-25 2008-05-02 Jubilant Organosys Limited NOVEL POLYMORPHIC FORMS OF l-BENZYL-4-[(5,6-DIMETHOXY-l-INDANONE)-2-YL]METHYL PIPERIDINE [DONEPEZIL] AND PROCESS FOR PREPARING THE SAME
WO2008051599A2 (en) 2006-10-27 2008-05-02 Medivation Neurology, Inc. Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil
US20080269348A1 (en) * 2006-11-07 2008-10-30 Phil Skolnick Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
US8138377B2 (en) * 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
WO2008111590A2 (en) * 2007-03-05 2008-09-18 Eisai R & D Management Co., Ltd. Ampa and nmda receptor antagonists for neurodegenerative diseases
JP2010524844A (ja) * 2007-04-26 2010-07-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 認知症のためのシンナミド化合物
US20090069374A1 (en) * 2007-06-06 2009-03-12 Phil Skolnick Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
WO2010071216A1 (en) * 2008-12-17 2010-06-24 Eisai R&D Management Co., Ltd. Polymorphic crystal of donepezil and process for producing the same
AU2011215870B2 (en) * 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2366378A1 (de) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Donepezilformulierungen mit verzögerter Freisetzung
WO2011127235A1 (en) 2010-04-07 2011-10-13 Eisai Inc. Combination therapy for the treatment of dementia
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
WO2012053016A1 (en) 2010-10-22 2012-04-26 Cadila Healthcare Limited Sustained release pharmaceutical compositions of donepezil
US20140206740A1 (en) 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
TW201540301A (zh) 2013-08-16 2015-11-01 Takeda Gmbh 以ｐｄｅ４抑制劑治療認知損傷
MX2017013791A (es) 2015-05-08 2018-03-01 Dow Global Technologies Llc Proceso para composiciones de poliolefina espumantes usando una mezcla de azodicarbonamida/citrato como agente nucleante.
US10925834B2 (en) 2015-05-22 2021-02-23 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
US10369187B2 (en) 2017-02-09 2019-08-06 Vanderbilt University Peptide regulators of JNK family kinases
PL3692188T3 (pl) 2017-10-06 2024-03-04 Lenzing Aktiengesellschaft Urządzenie do wytłaczania filamentów i wytwarzania włóknin otrzymanych metodą spod filiery
ES2970355T3 (es) 2019-05-17 2024-05-28 Chemiefaser Lenzing Ag Procedimiento y dispositivo para la limpieza de boquillas durante la producción de velo de hilatura de celulosa
CN112939846B (zh) * 2019-11-26 2023-12-26 中国科学院上海药物研究所 一种乙酰胆碱酯酶抑制剂的晶型及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
TW513409B (en) * 1996-06-07 2002-12-11 Eisai Co Ltd Polymorphs of donepezil hydrochloride
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
SI9720038B (sl) 1996-06-07 2010-06-30 Eisai Co Ltd Polimorfi donepezil hidroklorida in postopek izdelave

Also Published As

Publication number Publication date
EP1048653B1 (de) 2004-03-03
PT1048653E (pt) 2004-07-30
WO1999029668A1 (fr) 1999-06-17
US6245911B1 (en) 2001-06-12
ES2218869T3 (es) 2004-11-16
DK1048653T3 (da) 2004-05-24
EP1048653A4 (de) 2001-03-07
DE69822218T2 (de) 2005-02-03
EP1048653A1 (de) 2000-11-02
ATE260896T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
DE69822218D1 (de) Donepezil polykristalle und verfharen zu ihrer herstellung
MA23257A1 (fr) Nouvelle forme de compose demagnesium d'omeprazole etson utilisation .
NO941678D0 (no) nor-gallesyrederivater, fremgangsmåte for fremstilling og anvendelse av dem som legemiddel
CA2119853A1 (fr) Nouvelles pyridothiadiazines, leurs procedes de preparation, et les compositions pharmaceutiques qui les contiennent
NO933200D0 (no) Substituerte cykloheksanderivater, fremgangsm}te til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
PT92307A (pt) Processo para a preparacao de derivados de 3,5-dimetil-4-metoxipiridina e de produtos intermediarios
AU642053B2 (en) Novel compounds of N-benzoylproline, process for their preparation and pharmaceutical compositions containing them
ATE111909T1 (de) Heterocyclisch substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
AU6602394A (en) New alpha-amino acid compounds, a process for the preparation thereof and pharmaceutical compositions containing them
ATE66209T1 (de) Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
AU4861693A (en) New chromene compounds having a triene side chain, process for the preparation thereof, and pharmaceutical compositions containing them
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
BR9103676A (pt) Processo para a elaboracao de residuos de reacao da producao de dioxido de titanio
ATA168395A (de) Neue kristallform von morphin-6-glucuronid
GR3033099T3 (en) Process for the preparation of 7-(3-amino- and 3-aminomethyl-1-pyrrolidinyl)-3-quinolinonecarboxylic and -naphthyridinonecarboxylic acids.
ATE80890T1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
AU6187394A (en) New pyrrolopyrazine compounds, processes for their preparation and the pharmaceutical compositions which contain them
CA2149007A1 (en) Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases
ATE173734T1 (de) Heteroarenylpiperazine, verfahren zu ihrer herstellung und ihre anwendung als medikamente
HUP9603201A2 (en) Substituted benzene dicarboxylic acid diguanidides, process for producing them, their use for preparing pharmaceutical compositions and diagnostics and pharmaceutical compositions containing the said compounds
GR3023939T3 (en) (Thia) cycloalkyl(b)indoles, process of their preparation and compositions containing it.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition